Company / Book Value per Share
RIGEL PHARMACEUTICALS INC Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$22.105
FY2025
5-year range
-$0.165 / $22.105
FY2021-FY2025
Trend
+11653.2%
vs FY2024
Sector context
#24 of 209
Health Care
What the data says
Book Value per Share changed +11653% YoY in FY2025, a notable deviation from the 9-year average annual change of +1282%.
Based on SEC 10-K filings.
$22.105 in FY2025 with a 5-year CAGR of +155.6%. Top quartile in the Health Care sector.
Improved from -$0.165 to $22.105 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +155.6%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 209This company $22.105 Sector average $215.686
▼
-89.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +155.6%, indicating consistent growth.
- In FY2025, book value per share increased 11653.2% year-over-year.
- Ranks #24 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.105 | +11653.2% |
| FY2024 | $0.188 | +213.9% |
| FY2023 | -$0.165 | -108.2% |
| FY2022 | -$0.079 | -144.2% |
| FY2021 | $0.179 | -11.4% |
| FY2020 | $0.203 | -37.1% |
| FY2019 | $0.322 | -14.1% |
| FY2018 | $0.375 | -53.0% |
| FY2017 | $0.797 | +36.7% |
| FY2016 | $0.583 | -43.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026